• About us
• Contact

Advertisement

Person › Details

Malcolm Weir (Heptares Therapeutics Ltd. (Sosei Heptares))

Weir, Malcolm (Heptares 2007– CEO + co-founder before Inpharmatica 2000–2006 CEO before GSK/Glaxo since 1983)

 

	Organisation	Heptares Therapeutics Ltd. (Sosei Heptares)
	Today	Nxera Pharma UK Ltd.
	Group	Nxera Pharma (Group)
	Former/major organisation	Inpharmatica Ltd.
	Today	Galapagos (Group)
	Group	Galapagos (Group)
	Product	GPCR inhibitor
	Product 2	drug discovery

Record changed: 2019-08-07

Advertisement

More documents for Malcolm Weir

• [1] Sosei Group Corporation (d/b/a Sosei Heptares). (8/5/19). "Press Release: Sosei Heptares and Takeda Enter into New Strategic Multi-target Research, Development and Commercialization Partnership". Tokyo & London....
• [2] Sosei Group Corporation (d/b/a Sosei Heptares). (7/16/19). "Press Release: Sosei Heptares Enters into Multi-target Research Collaboration and License Agreement with Genentech". Tokyo & London....
• [3] Sosei Group Corporation (d/b/a Sosei Heptares). (2/4/19). "Press Release: Sosei Heptares Announces Medicxi to Invest up to €40 Million in New Collaboration Based on Its Orexin Agonist Program". Tokyo & London....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.